Free tool

Diagnostics stocks

We cover 14 companies grouped under the Diagnostics theme. The median market value in the group is $265.61M. Across the group, the median move over the past trading day is +0.09%. Price change over the past year runs from −51.7% to +10.2% across the middle 80 percent of the group, with a median of −16.2%.

Other lists in this group

Table

14 of 150 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y return
DIA.WADiagnostyka S.A.$1.54BSmall cap−17.76%
CEVI.STCellaVision AB (publ)$410.67MSmall cap−5.28%
NIOX.LNIOX Group Plc$392.35MSmall cap−9.49%
VOX.WAVoxel S.A.$376.42MSmall cap−18.11%
N3B.FAnbio Biotechnology$361.87MSmall cap−83.42%
SBS.DEStratec SE$322.43MSmall cap−16.91%
IDHC.LIntegrated Diagnostics Holdings plc$298.80MSmall cap+16.89%
ALERS.PAEurobio Scientific Société anonyme$232.43MSmall cap−21.89%
S2B.WASyn2bio S.A.$151.66MSmall cap+76.47%
EKF.LEKF Diagnostics Holdings plc$145.56MSmall cap−15.56%
BVXP.LBioventix PLC$124.26MSmall cap−30.64%
SCP.WAScope Fluidics S.A.$120.06MSmall cap−9.90%
S84.FScope Fluidics S.A.$118.77MSmall cap−10.43%
DVYSR.STDevyser Diagnostics AB (publ)$105.23MSmall cap−60.78%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse